GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eckert & Ziegler SE (CHIX:EUZd) » Definitions » Beneish M-Score

Eckert & Ziegler SE (CHIX:EUZD) Beneish M-Score : -3.03 (As of Jan. 18, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Eckert & Ziegler SE Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.03 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Eckert & Ziegler SE's Beneish M-Score or its related term are showing as below:

CHIX:EUZd' s Beneish M-Score Range Over the Past 10 Years
Min: -3.19   Med: -2.51   Max: -2.13
Current: -3.03

During the past 13 years, the highest Beneish M-Score of Eckert & Ziegler SE was -2.13. The lowest was -3.19. And the median was -2.51.


Eckert & Ziegler SE Beneish M-Score Historical Data

The historical data trend for Eckert & Ziegler SE's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eckert & Ziegler SE Beneish M-Score Chart

Eckert & Ziegler SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.19 -2.69 -2.19 -2.28 -2.74

Eckert & Ziegler SE Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.40 -2.74 -2.85 -2.75 -3.03

Competitive Comparison of Eckert & Ziegler SE's Beneish M-Score

For the Medical Devices subindustry, Eckert & Ziegler SE's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eckert & Ziegler SE's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eckert & Ziegler SE's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Eckert & Ziegler SE's Beneish M-Score falls into.



Eckert & Ziegler SE Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Eckert & Ziegler SE for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8303+0.528 * 0.9677+0.404 * 0.6408+0.892 * 1.1556+0.115 * 0.856
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1131+4.679 * -0.068893-0.327 * 1.0501
=-3.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Total Receivables was €47.5 Mil.
Revenue was 70.113 + 77.763 + 67.619 + 62.227 = €277.7 Mil.
Gross Profit was 34.018 + 38.089 + 34.895 + 26.505 = €133.5 Mil.
Total Current Assets was €277.2 Mil.
Total Assets was €480.9 Mil.
Property, Plant and Equipment(Net PPE) was €115.9 Mil.
Depreciation, Depletion and Amortization(DDA) was €14.4 Mil.
Selling, General, & Admin. Expense(SGA) was €30.1 Mil.
Total Current Liabilities was €99.9 Mil.
Long-Term Debt & Capital Lease Obligation was €42.7 Mil.
Net Income was 5.346 + 9.544 + 8.487 + 6.008 = €29.4 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = €0.0 Mil.
Cash Flow from Operations was 26.02 + 10.142 + 3.587 + 22.768 = €62.5 Mil.
Total Receivables was €49.5 Mil.
Revenue was 65.902 + 60.032 + 57.931 + 56.472 = €240.3 Mil.
Gross Profit was 32.47 + 29.918 + 27.45 + 21.968 = €111.8 Mil.
Total Current Assets was €196.9 Mil.
Total Assets was €443.5 Mil.
Property, Plant and Equipment(Net PPE) was €120.2 Mil.
Depreciation, Depletion and Amortization(DDA) was €12.5 Mil.
Selling, General, & Admin. Expense(SGA) was €23.4 Mil.
Total Current Liabilities was €80.1 Mil.
Long-Term Debt & Capital Lease Obligation was €45.1 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(47.45 / 277.722) / (49.457 / 240.337)
=0.170854 / 0.205782
=0.8303

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(111.806 / 240.337) / (133.507 / 277.722)
=0.465205 / 0.480722
=0.9677

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (277.232 + 115.857) / 480.919) / (1 - (196.932 + 120.151) / 443.473)
=0.18263 / 0.285
=0.6408

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=277.722 / 240.337
=1.1556

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(12.538 / (12.538 + 120.151)) / (14.377 / (14.377 + 115.857))
=0.094492 / 0.110394
=0.856

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(30.12 / 277.722) / (23.418 / 240.337)
=0.108454 / 0.097438
=1.1131

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((42.7 + 99.921) / 480.919) / ((45.128 + 80.119) / 443.473)
=0.296559 / 0.282423
=1.0501

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(29.385 - 0 - 62.517) / 480.919
=-0.068893

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Eckert & Ziegler SE has a M-score of -3.03 suggests that the company is unlikely to be a manipulator.


Eckert & Ziegler SE Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Eckert & Ziegler SE's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Eckert & Ziegler SE Business Description

Traded in Other Exchanges
Address
Robert-Rossle-Street 10, Berlin, BB, DEU, 13125
Eckert & Ziegler SE is a provider of isotope technology for medical, scientific, and industrial use. It is predominantly engaged in the business of cancer therapy, industrial radiometry, and nuclear medical imaging. The company's segments are Medical, Isotope Products, and Other. The Isotope Products segment which generates key revenue, manufactures and distributes standards and radiation sources for medical and industrial purposes. The Medical segment provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. The Other segment comprises the items of the holding company. Geographically, the company generates a majority of its revenue from Europe and the rest from North America, Asia/Pacific, and other regions.

Eckert & Ziegler SE Headlines

No Headlines